References
- Blackwell LF, Delwyn GC, Brown S. Identifying ovulatory cycles and the day of ovulation by the mis-use of pregnanediol glucuronide excretion rate thresholds. Eur J Contracept Reprod Health Care. 2018;23(5):390–391.
- Rosetta L, Thalabard JC, Tanniou J, et al. Ovulatory status and menstrual cycle duration assessed by self-collection of urine on pH strips in a population-based sample of French women not using hormonal contraception. Eur J Contracept Reprod Health Care. 2017; 22(6):450–458.
- Joffe M, Genetic damage and male reproduction. Chapter 2. In: Nicholas Mascie-Taylor CG, Rosetta L, editors. Reproduction and adaptation. New York, Cambridge (UK): Cambridge University Press; 2011. p. 17–49.
- Sufi SB, Donaldson A. Design of immunoassays for use in developing countries. Prog Clin Biol Res. 1988;285:331–341.
- Wasalathanthri S, Tennekoon KH, Sufi S. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity. Ceylon Med J. 2011;48:4–6.
- Ahsan R, Sufi S, Tangkananond W, et al. Laboratory method manual for enzyme immunoassay of urinary pregnanediol- 3alpha-glucuronide and estrone-3-glucuronide. 2nd ed. 1992.
- Kassam A, Overstreet J, Snow-Harter C, et al. Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Environ Health Perspect. 1996;104:408–413.
- Waller K, Swan S, Windham G, et al. Use of urinary biomarkers to evaluate menstrual function in healthy premenopausal women. Am J Epidemiol. 1998;147:1071–1080.
- O'Connor KA, Brindle E, Miller RC, et al. Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method. Hum Reprod. 2006;21:1442–1452.